Medicure (TSE:MPH) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Medicure Inc. has signed an agreement to acquire intellectual property from CanAm Bioresearch Inc., focusing on new chemical entities with potential therapeutic applications. The deal includes an initial cash payment and additional milestone payments upon filing and approval of new drug applications. Medicure expects these acquisitions to enhance its pharmaceutical development and commercialization efforts in the United States.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.
